Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-center, Exploratory Study on Predicting Neoadjuvant Therapy Efficacy and Prognosis in Pan-gastrointestinal Cancer Patients Based on Intratumoral Microbiome Characteristics and Their Functional Targets.

NCT07263620 is registered in ClinicalTrials.gov with Tianjin Medical University Cancer Institute and Hospital as lead sponsor.

NCT NCT07263620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07263620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-center, Exploratory Study on Predicting Neoadjuvant Therapy Efficacy and Prognosis in Pan-gastrointestinal Cancer Patients Based on Intratumoral Microbiome Characteristics and Their Functional Targets.
Lead sponsor
Tianjin Medical University Cancer Institute and Hospital
Phase
Observational
Overall status
Completed
Start date
October 1, 2025
Completion date
September 18, 2026
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

digestive system malignancies